论文部分内容阅读
作者收集1975年以来的48篇文献中29,226例鼻咽癌病人放射治疗结果和存活率的资料。作者见到,放疗结束后,原发瘤临床完全消退率:总指标68.8%(σ17.8,m4.2),T_196.2%(σ5.3,m3.7),T_284.8%(σ14.6,m7.3),T_369.0%(σ7.8,m3.5),T_445.6%(σ13.4,m5.2)。但是经过1年,有42.4%(σ11.8,m10.6)肿瘤复发,特别是T_3和T_4。4.3%(σ1.69,m1.2)对放疗完全不敏感。1年存活率:总指标75.9%(σ7.9,m1.9),T_185.8%(σ11.4,m5.7),T_285.7%(σ11.4,m5.7),T_378.3%(σ9.3,m4.1),T_442.0%(σ13.1,m6.5)。2年存活率:总指标62.5%(σ13.3,m2.9),T_183.3%(σ10.3,m5.1),T_281.7%(σ11.8,m5.9),T_365.0%(σ
The authors collected data from 29,226 nasopharyngeal cancer patients from radiotherapy and survival rates in 48 articles since 1975. The authors observed that after radiotherapy, the clinical complete regression rate of primary tumors was 68.8% (σ17.8, m4.2), T_196.2% (σ5.3, m3.7), and T_284.8% (σ14). .6, m7.3), T_369.0% (σ7.8, m3.5), T_445.6% (σ13.4, m5.2). However, after one year, 42.4% (σ11.8, m10.6) tumors relapsed, especially T_3 and T_4. 4.3% (σ1.69, m1.2) was completely insensitive to radiotherapy. 1 year survival rate: 75.9% of the total index (σ7.9, m1.9), T_185.8% (σ11.4, m5.7), T_285.7% (σ11.4, m5.7), T_378.3 % (σ9.3, m4.1), T_442.0% (σ13.1, m6.5). 2 year survival rate: total indicators 62.5% (σ13.3, m2.9), T_183.3% (σ10.3, m5.1), T_281.7% (σ11.8, m5.9), T_365.0 %(σ